Ozempic shortage pain to continue until year’s end

TGA underscores ‘limited availability’ means drug should still only be prescribed for type-2 diabetes There will be continued “limited availability” of diabetes drug Ozempic until 31 December 2023 due to “unexpected increase in consumer demand” the Therapeutic Goods Administration (TGA) has announced on its website. The TGA update comes just as the theoretical June 30

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous Chemist Warehouse plans 'up to' 20 Irish outlets
Next Should public hospitals be able to provide CTG medicines?